179 related articles for article (PubMed ID: 33939138)
1. High Neutrophil-Lymphocyte Ratio and Delta Neutrophil-Lymphocyte Ratio Are Associated with Increased Mortality in Patients with Hepatocellular Cancer.
Rich NE; Parvathaneni A; Sen A; Odewole M; Arroyo A; Mufti AR; Kerr TA; Grant L; Tujios SR; Mayo MJ; Lee WM; Yang JD; Yokoo T; Gopal P; Hoshida Y; Zhu H; Yopp AC; Marrero JA; Singal AG
Dig Dis Sci; 2022 Jun; 67(6):2666-2676. PubMed ID: 33939138
[TBL] [Abstract][Full Text] [Related]
2. Combination of alpha-fetoprotein and neutrophil-to-lymphocyte ratio to predict treatment response and survival outcomes of patients with unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors.
Zhu HF; Feng JK; Xiang YJ; Wang K; Zhou LP; Liu ZH; Cheng YQ; Shi J; Guo WX; Cheng SQ
BMC Cancer; 2023 Jun; 23(1):547. PubMed ID: 37322411
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma.
Personeni N; Giordano L; Abbadessa G; Porta C; Borbath I; Daniele B; Van Laethem JL; Van Vlierberghe H; Trojan J; De Toni EN; Gasbarrini A; Lencioni M; Lamar ME; Wang Y; Shuster D; Schwartz B; Santoro A; Rimassa L
Oncotarget; 2017 Feb; 8(9):14408-14415. PubMed ID: 28122337
[TBL] [Abstract][Full Text] [Related]
4. Stratified neutrophil-to-lymphocyte ratio accurately predict mortality risk in hepatocellular carcinoma patients following curative liver resection.
Huang GQ; Zhu GQ; Liu YL; Wang LR; Braddock M; Zheng MH; Zhou MT
Oncotarget; 2016 Feb; 7(5):5429-39. PubMed ID: 26716411
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis.
Xiao WK; Chen D; Li SQ; Fu SJ; Peng BG; Liang LJ
BMC Cancer; 2014 Feb; 14():117. PubMed ID: 24559042
[TBL] [Abstract][Full Text] [Related]
6. The Prognostic Role of a Combined Fibrinogen and Neutrophil-to-Lymphocyte Ratio Score in Patients with Resectable Hepatocellular Carcinoma: A Retrospective Study.
Kong W; Xu H; Cheng J; Fang Z; Wang H; Zhang J; Wang X; Dai T; Gao Y
Med Sci Monit; 2020 Jan; 26():e918824. PubMed ID: 31929496
[TBL] [Abstract][Full Text] [Related]
7. Prognostication of inflammatory cells in liver transplantation: Is the waitlist neutrophil-to-lymphocyte ratio really predictive of tumor biology?
McVey JC; Sasaki K; Firl DJ; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Miller CC; Hashimoto K; Aucejo FN
Clin Transplant; 2019 Dec; 33(12):e13743. PubMed ID: 31655000
[TBL] [Abstract][Full Text] [Related]
8. Using Pre-Treatment Neutrophil-to-Lymphocyte Ratio to Predict the Prognosis of Young Patients with Hepatocellular Carcinoma Implemented Minimally Invasive Treatment.
Sun S; Wang X; Chen J
J Adolesc Young Adult Oncol; 2020 Feb; 9(1):85-89. PubMed ID: 31621472
[No Abstract] [Full Text] [Related]
9. Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV-related hepatocellular carcinoma.
Ding Y; Liu K; Xu Y; Zhao Q; Lou S; Xiang X; Yan L; Cao Z; Xie Q; Zhu C; Bao S; Wang H
Cancer Med; 2020 May; 9(9):3057-3069. PubMed ID: 32150664
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
[TBL] [Abstract][Full Text] [Related]
11. Prognostic effect of preoperative neutrophil-lymphocyte ratio is related with tumor necrosis and tumor-infiltrating lymphocytes in hepatocellular carcinoma.
Ha SY; Choi S; Park S; Kim JM; Choi GS; Joh JW; Park CK
Virchows Arch; 2020 Dec; 477(6):807-816. PubMed ID: 32483662
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.
Zheng J; Cai J; Li H; Zeng K; He L; Fu H; Zhang J; Chen L; Yao J; Zhang Y; Yang Y
Cell Physiol Biochem; 2017; 44(3):967-981. PubMed ID: 29179180
[TBL] [Abstract][Full Text] [Related]
13. [Correlation between postoperative neutrophil to lymphocyte ratio and recurrence and prognosis of hepatocellular carcinoma after radical liver resection].
Wu XL; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):365-371. PubMed ID: 29860764
[No Abstract] [Full Text] [Related]
14. Prognostic value of preoperative peripheral neutrophil-to-lymphocyte ratio in patients with HBV-associated hepatocellular carcinoma after radical hepatectomy.
Fu SJ; Shen SL; Li SQ; Hua YP; Hu WJ; Liang LJ; Peng BG
Med Oncol; 2013 Dec; 30(4):721. PubMed ID: 24026659
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil-to-lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma: a Western perspective.
Sullivan KM; Groeschl RT; Turaga KK; Tsai S; Christians KK; White SB; Rilling WS; Pilgrim CH; Gamblin TC
J Surg Oncol; 2014 Feb; 109(2):95-7. PubMed ID: 24122764
[TBL] [Abstract][Full Text] [Related]
16. A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI).
Ji F; Liang Y; Fu SJ; Guo ZY; Shu M; Shen SL; Li SQ; Peng BG; Liang LJ; Hua YP
BMC Cancer; 2016 Feb; 16():137. PubMed ID: 26907597
[TBL] [Abstract][Full Text] [Related]
17. Underlying liver disease and advanced stage liver cancer are associated with elevated neutrophil-lymphocyte ratio.
Wong L; Bozhilov K; Hernandez B; Kwee S; Chan O; Ellis L; LeMarchand L
Clin Mol Hepatol; 2019 Sep; 25(3):305-316. PubMed ID: 31001964
[TBL] [Abstract][Full Text] [Related]
18. The Prognostic Value of Inflammation Factors in Hepatocellular Carcinoma Patients with Hepatic Artery Interventional Treatments: A Retrospective Study.
Guo L; Ren H; Pu L; Zhu X; Liu Y; Ma X
Cancer Manag Res; 2020; 12():7173-7188. PubMed ID: 33061563
[TBL] [Abstract][Full Text] [Related]
19. Combination of Tertiary Lymphoid Structure and Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients With Hepatocellular Carcinoma.
Wen S; Chen Y; Hu C; Du X; Xia J; Wang X; Zhu W; Wang Q; Zhu M; Chen Y; Shen B
Front Immunol; 2021; 12():788640. PubMed ID: 35095864
[TBL] [Abstract][Full Text] [Related]
20. The blood neutrophil-to-lymphocyte ratio predicts survival in patients with advanced hepatocellular carcinoma receiving sorafenib.
Zheng YB; Zhao W; Liu B; Lu LG; He X; Huang JW; Li Y; Hu BS
Asian Pac J Cancer Prev; 2013; 14(9):5527-31. PubMed ID: 24175853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]